You are using an older browser version. Please use a supported version for the best MSN experience.

IONIS PHARMACEUTICALS, INC.

NASDAQ: IONS
51.39
+0.10
+0.20%
  • Key statistics
  • Growth
  • Profitability
  • Price ratios
Industry Biotechnology & Medical Research
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 1.12B

    • Net Income

    • 294.15M

    • Market Cap.

    • 5.26B

    • Enterprise Value

    • 3.89B

    • Net Profit Margin %

    • 27.01

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.46

    • Forward P/E

    • -76.29

    • Price/Sales

    • 0.00

    • Price/Book Value

    • 4.89

    • Price/Cash flow

    • 16.40

      • EBITDA

      • 380.34M

      • Return on Capital %

      • 4.03

      • Return on Equity %

      • 9.86

      • Return on Assets %

      • 4.03

      • Book Value/Share

      • 9.87

      • Shares Outstanding

      • 101.62M

      • Last Split Factor (Date)

      • 1:0 (-)

      • Last Dividend (Ex-Date)

      • 0.00 (-)

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      9/18/2020
      Buy
        • 1 Year Price Target

        • 69.00

        • Analysts

        • 13

        • EPS Estimate

        • 2.17

        • Cashflow Estimate

        • -

        Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

        • Sales (Revenue)

          Q/Q (Last Year)

        • -11.16

        • 13.76

        • Net Income

          YTD/YTD (Last Year)

        • 604.03

        • -9.92

        • Net Income

          Q/Q (Last Year)

        • -3,535.27

        • -26.37

        • Sales (Revenue)

          5-Year Annual Average

        • 39.28

        • -

        • Net Income

          5-Year Annual Average

        • -

        • -

        • Dividends

          5-Year Annual Average

        • -

        • -

        • Profit Margins (%)

        • Company

        • Industry

        • Gross Margin

        • 99.61

        • 61.57

        • Pre-Tax Margin

        • 30.89

        • -18.39

        • Net Profit Margin

        • 27.01

        • -14.02

        • Average Gross Margin

          5-Year Annual Average

        • -

        • 64.03

        • Average Pre-Tax Margin

          5-Year Annual Average

        • 3.75

        • 0.18

        • Average Net Profit Margin

          5-Year Annual Average

        • 4.63

        • -3.92

        • Price Ratios

        • Company

        • Industry

        • Current P/E Ratio

        • 57.15

        • 57.15

        • P/E Ratio 5-Year High

        • 58.92

        • -

        • P/E Ratio 5-Year Low

        • 29.34

        • -

        • Price/Sales Ratio

        • 4.64

        • 9.42

        • Price/Book Value

        • 4.89

        • 6.30

        • Price/Cash Flow Ratio

        • 16.40

        • 21.22

        Current Historical
        • Financial health
        • Trading statistics
        • Management effectiveness
        Industry Biotechnology & Medical Research
        • Financial Ratios

        • Company

        • Industry

        • Debt/Equity Ratio

        • 0.58

        • 0.44

        • Current Ratio

        • 10.94

        • 3.44

        • Quick Ratio

        • 9.90

        • 3.03

        • Leverage Ratio

        • 2.24

        • 1.94

        • Book Value/Share

        • 9.87

        • 1.79

        • Key Metrics

        • Company

          • Shares Short

            as of -

          • -

          • Short Ratio

            as of -

          • -

          • Short % of Float

            as of -

          • -

          • Shares Short

            prior month

          • -

          • Trailing Annual Dividend Yield

          • -

          • 5 Year Average Dividend Yield

          • 0.00

          • Key Metrics

          • Company

            • Payout Ratio

            • 0.00

            • Dividend Date

            • -

            • Ex-Dividend Date

            • -

            • Last Split Factor

              new per old

            • 1:0

            • Last Split Date

            • -

            • Key Metrics

            • Company

            • Industry

            • Return on Equity %

              (5-Year Average)

            • 9.86

              (7.81)

            • -14.13

              (-3.07)

            • Return on Assets %

              (5-Year Average)

            • 4.03

              (1.69)

            • -6.66

              (-1.31)

            • Return on Capital %

              (5-Year Average)

            • 4.73

              (2.03)

            • -8.59

              (-1.58)

            • Income/Employee

            • 390.30k

            • -103.70k

            • Inventory Turnover

            • 0.33

            • 2.93

            • Asset Turnover

            • 0.38

            • 0.38

            Current Historical
            AdChoices
            AdChoices
            AdChoices
            image beaconimage beaconimage beacon